ITMCTR1900002740
Not yet recruiting
Phase 4
A randomized, double-blind, positive-drug, parallel-controlled multi-center clinical trial of the efficacy and safety of Chaishi Tuire granules for influenza.(RADICAL)
China-Japan Friendship Hospital0 sitesTBD
ConditionsInfluenza
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Influenza
- Sponsor
- China-Japan Friendship Hospital
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Conforms to the western medical diagnosis and treatment standard of influenza (revised version 2018\);
- •2\. Meet the standard of syndrome differentiation of wind\-heat syndrome;
- •3\. Between 18 and 75 years old;
- •4\. Duration within 48 hours and less, axillary temperature \>\= 38 degree C;
- •5\. Rapid virus antigen test results were positive;
- •6\. Agree and sign informed consent.
Exclusion Criteria
- •1\. Within 12 hours before enrollment, receive relevant drug treatment, such as antibiotics, antiviral drugs, hormone drugs, antipyretic and analgesic drugs, and drugs for treating influenza indicated in the instruction manual;
- •2\. Complications such as sinusitis, acute bronchitis and pneumonia;
- •3\. Patients with the following serious lung diseases (such as asthma, chronic bronchitis, tuberculosis, etc.), primary cardiovascular diseases, liver diseases, kidney diseases, hematological diseases, or other serious diseases that affect their survival;
- •4\. Influenza vaccine was given within 12 months before the trial began;
- •5\. The upper limit of ALT and AST \> normal value is 1\.5 times, and the blood Cr exceeds the upper limit of normal value;
- •6\. Immunodeficiency or immunosuppression, such as AIDS, malignant tumors, organ transplantation, or taking immunosuppressive drugs or glucocorticoids within the last 3 months;
- •7\. Allergic constitution (allergic to more than 2 kinds of substances), or allergic to the components of this preparation or the control drug;
- •8\. Pregnant, pregnant or lactating women;
- •9\. Have participated in other clinical trials within the past month;
- •10\. Patients who are unable to cooperate or who are mentally ill are considered unfit to participate in this clinical trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Bioequivalence study with clinical endpoint in the treatment of subjects with chronic open-angle glaucoma or ocular hypertension in both eyes.CTRI/2022/04/042203Amneal EU Limited
Not yet recruiting
Phase 4
Randomized, double-blind, positive drug parallel control, multi-center Chinese medicine variety protection clinical trial on the efficacy and safety of Baihe Gujin tablet in the treatment of post-cold cough (lung-kidney yin deficiency syndrome).cough after a coldITMCTR2200006021Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Not yet recruiting
Phase 4
Randomized, double-blind, positive drug parallel control, multi-center Chinese medicine variety protection clinical trial on the efficacy and safety of Baihe Gujin tablet in the treatment of chronic pharyngitis (lung-kidney yin deficiency syndrome)chronic pharyngitisITMCTR2200006022Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Not yet recruiting
Phase 4
Randomized, double-blind, positive-drug parallel-controlled, multi-center clinical trial on the efficacy and safety of Baihe Gujin tablets in the treatment of cough caused by bronchiectasis (lung-kidney yin deficiency syndrome)Cough due to bronchiectasisITMCTR2200005979Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Completed
Not Applicable
A phase 4 clinical trial to compare the incidence of headache according to dosing regimen of Adinox® capsules in patients with transient ischemic attacks or ischemic strokeDiseases of the circulatory systemKCT0005457Chodang Pharm192